European Site Summit Solutions

  • Start Date:

    13 Nov 2023

  • End Date:

    14 Nov 2023

  • Location:

    Lisbon, Portugal

  • Region:


PPD is the leading provider of site and patient recruitment solutions with a proven record to keep patients at the forefront.

Our unique combination of global site locations, patient-centric and digital solutions, and forward-thinking services such as a patient concierge takes patient engagement, enrollment, and retention to a whole new level. We can be your single partner that accelerates development through all phases of your clinical trial.

Plenary Sessions

The Patient Voice: Technology Engagement

Date: Monday, 13 November 2023
Time: 11:30 – 12:15

How is technology shaping the evolution of medical research and patient engagement? Hear firsthand accounts from clinical trial participants who will share their perspectives on the technology used in our trials. Discover the power of the patient voice as we work together to enhance the patient experience with technology.

Ângela Papa, PharmD, MSc, Director, PPD, part of Thermo Fisher Scientific, Portugal

Aneta Sitarska Haber, MD, Associate Director, Regional Operational Delivery, Poland

EMA Guidance Perspectives On DCTs

Date: Monday, 13 November 2023
Time: 12:15 – 13:00

Explore the various approaches to the recent European Medicines Agency (EMA) guidance and gain insight into the future of decentralized trials across European countries. Uncover the potential impact of the guidance on research sites and hear regulatory experts’ perspectives on the evolving landscape of clinical research technology.

Jenna McDonnell, Senior Director, Consulting, Innovation & Strategy

Breakout Session I

The EMA Recommendations On DCT Elements In Clinical Trials


Date: Monday, 13 November 2023
Time: 14:00 – 15:00

There are advantages, challenges, and future implications of decentralized approaches in clinical research. Explore the transformative potential of DCTs and the significance of EMA’s recommendations in shaping the evolution of clinical trials.

Facilitator: Steven Burke, PhD, Director, strategic site collaboration/patient solutions, PPD, part of Thermo Fisher Scientific, Scotland, United Kingdom

Breakout Session III

Innovative Trials Designs: Ambitions & Experiences


Date: Monday, 13 November 2023
Time: 17:00 – 18:00

There are many new ways to conduct trials and as a result, trial designs are changing rapidly. Gain insights on the latest innovative trial designs and execution methods so that you can implement these approaches at the site level. Three Learning Objectives:

  1. Assess the impact of innovative trial designs on patient recruitment and retention.
  2. Identify potential challenges and barriers to implementing innovative trial designs at the site level.
  3. Propose strategies to overcome obstacles and ensure successful implementation of innovative trial designs.

Facilitator: Sofie Vanderplaetsen, MSc, Executive Director, Hematology Oncology TU, clinical research, PPD, part of Thermo Fisher Scientific, Belgium

Breakout Session IV

Country Comparison of Trial Regulations: Learning From Each Other

Legal & Regulatory

Date: Tuesday, 14 November 2023
Time: 12:30 – 13:30

Europe has a variety of regulations shaping the landscape of clinical trials across different nations. This session will look into the country-by-country nuances as we learn from one another’s experiences. Discover the exceptional strategies that thrive in specific regions and, in particular, examine how the regulations of esteemed bodies like the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA) impact other European countries.

Facilitator: Ângela Papa, PharmD, MSc, Director, PPD, part of Thermo Fisher Scientific, Portugal

Learn how our site and patient solutions can help you advance your drug development.